Pharm-Olam, LLC logo — Helping bring new therapies to light

Pharm-Olam, LLC

Helping bring new therapies to light

Founded 1988 United States Houston, United States 452 employees Biotechnology, Pharmaceutical

General Information

Company Name Pharm-Olam, LLC
Founded Year 1988
Location United States Houston, United States
Employees 452
Industries Biotechnology, Pharmaceutical
Social

BounceWatch is an independent company data service, not affiliated with Pharm-Olam, LLC. To contact Pharm-Olam, LLC, visit allucent.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Pharm-Olam, LLC compare?

A PDF of Pharm-Olam, LLC and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Pharm-Olam, LLC soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Pharm-Olam, LLC

Allucent is a biotechnology and pharmaceutical company that aims to facilitate the emergence of new therapies by addressing the unique obstacles faced by small and mid-sized biotech firms. Founded in 1988 with a slogan of "Helping bring new therapies to light," Allucent has evolved into a global provider of comprehensive drug development solutions. The company offers a wide range of services, including consulting, clinical operations, biometrics, and clinical pharmacology, encompassing various therapeutic areas. With a track record of more than 30 years of experience spanning over 60 countries, Allucent adopts a personalized partnership approach, providing valuable insights and expertise to support its clients in successfully navigating the complexities of delivering innovative treatments to patients. Currently headquartered in the United States, Allucent has not disclosed its last investment details or the involved investors.

Business keywords: biotech companies, drug development, clinical operations, consulting, biometrics, clinical pharmacology, therapeutic areas, global provider, individualized partnership, experience-driven insights, novel treatments, pharmaceutical industry, biopharmaceuticals

No funding data available for Pharm-Olam, LLC yet.

Pharm-Olam, LLC Alternatives & Competitors

View All Alternatives
Pharm-Olam, LLC vs

Chord Therapeutics is dedicated to bringing new treatments to patients affected by orphan diseases.

Series A
2-10 employees
Biotechnology, Pharmaceutical
Pharm-Olam, LLC vs

pharmaceutical

13 employees
Biotechnology, Pharmaceutical
Pharm-Olam, LLC vs

A pioneering chemoproteiomics-based drug discovery and development firm with bases in Seoul, Korea,...

Series B
2-10 employees
Biotechnology, Health Care

FAQ About Pharm-Olam, LLC

Helping bring new therapies to light
Pharm-Olam, LLC was founded in 1988.
Pharm-Olam, LLC is headquartered in Houston, United States.
Pharm-Olam, LLC operates in Biotechnology and Pharmaceutical. Its work centres on biotech companies, drug development, clinical operations and consulting.
Pharm-Olam, LLC has approximately 452 employees.
Top alternatives and competitors to Pharm-Olam, LLC include CHORD Therapeutics, NJS Associates Company, CG Pharmaceuticals, Zavante Therapeutics, Yamo Pharmaceuticals. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Pharm-Olam, LLC and CHORD Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Pharm-Olam, LLC, https://bouncewatch.com/company/allucent, updated 24 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes